Phase II Study of Stereotactic Magnetic Resonance Imaging (MRI) Guided On-table Adaptive Radiation Therapy (SMART) for Patients With Borderline or Inoperable Locally Advanced Pancreatic Cancer
Summary
The purpose of this phase II study is to evaluate the safety and tolerability of stereotactic magnetic resonance imaging (MRI) guided on-table adaptive radiation therapy (SMART) for patients with borderline or inoperable locally advanced pancreatic cancer.
General Information
NCT#: NCT03621644
Study ID: VR C2T2 - SMART - LAPC/BR
Trial Phase: Phase II
Trial Sponsor: Viewray Inc.
Therapies Used in This Trial: Radiation Therapy